Erin Hu , Arianne Caudal , Christopher D. Yan , Yanjun Zha , Uri Ladabaum , Joseph C. Wu
{"title":"来自Lynch综合征患者携带杂合MLH1突变的两种诱导多能干细胞系的产生","authors":"Erin Hu , Arianne Caudal , Christopher D. Yan , Yanjun Zha , Uri Ladabaum , Joseph C. Wu","doi":"10.1016/j.scr.2025.103832","DOIUrl":null,"url":null,"abstract":"<div><div>Lynch syndrome (LS), previously known as hereditary nonpolyposis colorectal cancer (HNPCC), is one of the most common hereditary cancer<!--> <!-->syndromes. LS is caused by a pathogenic mutation in one of the four DNA mismatch repair<!--> <!-->genes<!--> <em>MLH1</em>,<!--> <em>MSH2</em>,<!--> <em>MSH6</em>, or<!--> <em>PMS2</em>, or in<!--> <em>EPCAM</em>, which is upstream of<!--> <em>MSH2</em>. We generated two human induced pluripotent stem cell (iPSC) lines from LS patients carrying different single heterozygous missense mutations in the<!--> <em>MLH1</em> <!-->gene. Pluripotency, morphology, karyotype stability, and differentiation capacity of both lines were<!--> <!-->normal. These patient-specific iPSC lines are<!--> <!-->a valuable tool to investigate LS phenotypes and develop potential therapeutics.</div></div>","PeriodicalId":21843,"journal":{"name":"Stem cell research","volume":"88 ","pages":"Article 103832"},"PeriodicalIF":0.7000,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Generation of two induced pluripotent stem cell lines from Lynch syndrome patients carrying heterozygous MLH1 mutations\",\"authors\":\"Erin Hu , Arianne Caudal , Christopher D. Yan , Yanjun Zha , Uri Ladabaum , Joseph C. Wu\",\"doi\":\"10.1016/j.scr.2025.103832\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Lynch syndrome (LS), previously known as hereditary nonpolyposis colorectal cancer (HNPCC), is one of the most common hereditary cancer<!--> <!-->syndromes. LS is caused by a pathogenic mutation in one of the four DNA mismatch repair<!--> <!-->genes<!--> <em>MLH1</em>,<!--> <em>MSH2</em>,<!--> <em>MSH6</em>, or<!--> <em>PMS2</em>, or in<!--> <em>EPCAM</em>, which is upstream of<!--> <em>MSH2</em>. We generated two human induced pluripotent stem cell (iPSC) lines from LS patients carrying different single heterozygous missense mutations in the<!--> <em>MLH1</em> <!-->gene. Pluripotency, morphology, karyotype stability, and differentiation capacity of both lines were<!--> <!-->normal. These patient-specific iPSC lines are<!--> <!-->a valuable tool to investigate LS phenotypes and develop potential therapeutics.</div></div>\",\"PeriodicalId\":21843,\"journal\":{\"name\":\"Stem cell research\",\"volume\":\"88 \",\"pages\":\"Article 103832\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2025-09-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Stem cell research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1873506125001825\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stem cell research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1873506125001825","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Generation of two induced pluripotent stem cell lines from Lynch syndrome patients carrying heterozygous MLH1 mutations
Lynch syndrome (LS), previously known as hereditary nonpolyposis colorectal cancer (HNPCC), is one of the most common hereditary cancer syndromes. LS is caused by a pathogenic mutation in one of the four DNA mismatch repair genes MLH1, MSH2, MSH6, or PMS2, or in EPCAM, which is upstream of MSH2. We generated two human induced pluripotent stem cell (iPSC) lines from LS patients carrying different single heterozygous missense mutations in the MLH1 gene. Pluripotency, morphology, karyotype stability, and differentiation capacity of both lines were normal. These patient-specific iPSC lines are a valuable tool to investigate LS phenotypes and develop potential therapeutics.
期刊介绍:
Stem Cell Research is dedicated to publishing high-quality manuscripts focusing on the biology and applications of stem cell research. Submissions to Stem Cell Research, may cover all aspects of stem cells, including embryonic stem cells, tissue-specific stem cells, cancer stem cells, developmental studies, stem cell genomes, and translational research. Stem Cell Research publishes 6 issues a year.